Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02929069 · ClinicalTrials.gov registry record · NA
A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 254
- Enrollment target
NCT02929069: Completed NA study, sponsored by Yale University.
NCT02929069 is a NA study that has completed, run by Yale University. The registered enrollment target is 254 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02929069, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 254 participants
- Enrollment target
Study Summary
The intent of the proposed randomized controlled trial is to test the efficacy of a principle-based, transdiagnostic cognitive behavioral therapy (CBT) intervention that addresses the pathways through which minority stress compromises young gay and bisexual men's (YGBM) co-occurring mental (e.g., depression), behavioral (e.g., substance use), and sexual (e.g., condomless anal sex) health problems.
Primary Outcome
Our primary outcome is the presence (yes/no) of any condomless anal sex (CAS) in the absence of either PrEP or known undetectable viral load of HIV+ primary partners.The Time-Line Follow-Back Interview (TLFB) will be used to assess frequency of HIV risk behavior, including CAS, sex while under the influence of drugs or alcohol, and number of sexual partners, during the previous 3 months.
Interventions
- BEHAVIORAL ESTEEM
- BEHAVIORAL CMHT
- BEHAVIORAL VCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2016-09 |
| Est. Completion | 2020-06-16 |
| Phase | NA |
What the finished NCT02929069 record still lists
NCT02929069 is an interventional study that assigns participants to a tested intervention. The registered 254 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 3 interventions - of which ESTEEM is the first listed.
NCT02929069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02929069 about?
NCT02929069 is a clinical study titled "A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk". The intent of the proposed randomized controlled trial is to test the efficacy of a principle-based, transdiagnostic cognitive behavioral therapy (CBT) intervention that addresses the pathways through which minority stress compromises young gay and bisexual men's (YGBM) co-occurring mental (e.g., de...
What is the current status of trial NCT02929069?
This trial is currently completed. It is a NA study. The enrollment target is 254 participants. The study started on 2016-09. Estimated completion is 2020-06-16.
What interventions are being tested in trial NCT02929069?
The interventions under investigation include: ESTEEM (BEHAVIORAL), CMHT (BEHAVIORAL), VCT (BEHAVIORAL).
Who is sponsoring clinical trial NCT02929069?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02929069's enrollment target sits among peer trials
254 407th of 2000 higher than 1,594 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia